PrimeRFP SCOUT · Federal Contract Recompete Brief

N6264521D50184001 radiopharmaceuticals — Cardinal Health 414, LLC

Cardinal Health 414, LLC holds $77.1M across 461 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: Unrestricted.

Naval Medical Logistics Command
Awarding office
Cardinal Health 414, LLC
Recipient
—
Estimated value
6515
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract numberN6264521D5018
Also listed asN62645-21-D-5018
AgencyNaval Medical Logistics Command
Awarding officeNaval Medical Logistics Command
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentCardinal Health 414, LLC
UEICWN9UGL3NCL9
PSC6515
Related solicitationN6264521R0053

4001 RADIOPHARMACEUTICALS is a federal Unrestricted award for Naval Medical Logistics Command held by Cardinal Health 414, LLC. Estimated value —. Related solicitation N6264521R0053.

Bonuses end Sept 30

Want the durability read on N6264521D5018? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Cardinal Health 414, LLC — $77.1M obligated across 461 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($77.1M) · all agencies
Department of Veterans Affairs (VA)$64.4M · 84%Department of Defense (DOD)$10.4M · 13%Department of Health and Human Services (HHS)$2.3M · 3%Department of Justice (DOJ)$47K · 0%
Open full company profile →

Related awards

Same incumbent
36C24826N0035
RADIOPHARMACEUTICALS
$3.1M
Sep 30, 2026
W91YTZ21C0027
NEW FY22 RADIOPHARMACEUTICALS PR 0011603260
$2.8M
Sep 30, 2026
W91YTZ21P0135
MOD - FUND FY22 RADIOPHARMA
$2.0M
Sep 30, 2026
36C24425P0300
RADIOPHARMACEUTICALS-NETSPOT, ILLUCIX, XOFIGO
$920K
Sep 30, 2026
36C24926N0018
VARIOUS RADIOPHARMACEUTICALS INC EXERCISE OPTION YEAR 2
$819K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract N6264521D5018?

N6264521D5018 (4001 radiopharmaceuticals) is a Naval Medical Logistics Command award with an estimated value of —, currently held by Cardinal Health 414, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is N62645-21-D-5018?

N62645-21-D-5018 is the dashed form of PIID N6264521D5018 (4001 radiopharmaceuticals), held by Cardinal Health 414, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded N6264521D5018?

Naval Medical Logistics Command awarded N6264521D5018 to Cardinal Health 414, LLC.

Who is the incumbent on N6264521D5018?

Cardinal Health 414, LLC is the incumbent with $77.1M across 461 related awards in SCOUT’s public footprint.

When does Cardinal Health 414, LLC’s N6264521D5018 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on N6264521D5018? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/N6264521D5018